EFG Asset Management North America Corp. lowered its position in shares of Intra-Cellular Therapies, Inc. (NASDAQ:ITCI – Free Report) by 5.6% during the 2nd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 32,321 shares of the biopharmaceutical company’s stock after selling 1,912 shares during the quarter. […]